103 research outputs found

    Preparation of a New Iron-Carbon-Loaded Constructed Wetland Substrate and Enhanced Phosphorus Removal Performance

    No full text
    Iron-carbon substrates have attracted extensive attention in water treatment due to their excellent processing ability. The traditional iron-carbon substrate suffers from poor removal effects, separation of the cathode and anode, hardening, secondary pollution, etc. In this study, a new type of iron-carbon-loaded substrate (NICLS) was developed to solve the problems of traditional micro-electrolytic substrates. Through experimental research, a preparation method for the NICLS with Fe and C as the core, zeolite as the skeleton, and water-based polyurethane as the binder was proposed. The performance of the NICLS in phosphorus-containing wastewater was analyzed. The results are as follows: The optimal synthesis conditions of the NICLS are 1 g hydroxycellulose, wood activated carbon as the cathode, an activated carbon particle size of 200-60 mesh, and an Fe/C ratio of 1:1. Acidic conditions can promote the degradation of phosphorus by the NICLS. Through the characterization of the NICLS (scanning electron microscope (SEM), X-ray diffractometer (XRD), and energy-dispersive spectrometer (EDS), etc.), it is concluded that the mechanism of the NICLS phosphorus removal is a chemical reaction produced by micro-electrolysis. Using the NICLS to treat phosphorus-containing wastewater has the advantages of high efficiency and durability. Therefore, it can be considered that the NICLS is a promising material to remove phosphorus

    An Alternative Paradigm for Control System Design

    No full text
    An alternative framework for control design is presented in this paper. It compliments the existing theory in that: 1) it actively and systematically explores the use of nonlinear control mechanisms for better performance, even for linear plants; 2) it represents a control strategy that is rather independent of mathematical models of the plants, thus achieving inherent robustness and reducing design complexity. An overview of this design philosophy and associated algorithms are first introduced, followed by the summaries of preliminary analysis results and practical applications. It is evident that the proposed framework lends itself well in providing innovative solutions to practical problems while maintaining the simplicity and the intuitiveness of the existing technology, namely PID

    Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment

    No full text
    Although progress has been indeed made by nanomedicines, their efficacies for cancer treatment remain low, consequently leading to failures in translation to clinic. To improve the drug delivery efficiency, nanoparticles need to change size so as to fully utilize the enhanced permeability and retention (EPR) effect of solid tumor, which is the golden principle of nanoparticles used for cancer treatment. Herein, we employed cationic small-sized red emission bovine serum albumin (BSA) protected gold nanocluster (AuNC@CBSA, 21.06 nm) to both load indocyanine green (ICG) and act as imaging probe to realize theranostic. Then AuNC@CBSA-ICG was fabricated with negatively charged hyaluronic acid (HA) to form AuNC@CBSA-ICG@HA, which was about 200 nm to easily retain at tumor site and could be degraded by tumor-specific hyaluronidase into small nanoparticles for deep tumor penetration. The HA shell also endowed AuNC@CBSA-ICG@HA with actively targeting ability and hyaluronidase-dependent drug release. Furthermore, the quenching and recovery of fluorescence revealed the interaction between ICG and carrier, which was essential for the investigation of pharmacokinetic profiles. No matter in vitro or in vivo, AuNC@CBSA-ICG@HA showed markedly anti-tumor effect, and could suppress 95.0% of tumor growth on mice breast cancer model. All results demonstrated AuNC@CBSA-ICG@HA was potential for breast cancer therapy. KEY WORDS: Size-shrinkage, Drug release, Photothermal therapy, Theranostic, Breast cance

    Effect of ammonia stress on nitrogen metabolism of Ceratophyllum demersum

    No full text
    The objective of the present study was to determine the effect of total ammonia N concentration and pH on N metabolism of Ceratophyllum demersum and to evaluate stress as a result of inorganic N enrichment in the water column on submerged macrophytes. Carefully controlled pH values distinguished between the effects of un-ionized NH3 and ionized NH4+. The results showed that the most obvious consequence of ammonia addition was an overall increase in ammonia content and decrease in nitrate content in all tissues of fertilized plants. The activities of nitrate reductase and glutamine synthetase were inhibited by long-term ammonia addition. At the same time, ammonia addition significantly decreased soluble protein content and increased free amino acid content in all treatments. Another clear effect of ammonia addition was a decrease in carbon reserves. Therefore, the authors concluded that increased ammonia availability could affect plant survival and lead to a decline in C. demersum proliferation through a decrease in their carbon reserves. This interaction between N and C metabolism helps to explain changes in benthic vegetation as a result of steadily increasing coastal water eutrophication

    Enhanced Adsorption of Sulfonamides by Attapulgite-Doped Biochar Prepared with Calcination

    No full text
    The extensive use of sulfonamides seriously threatens the safety and stability of the ecological environment. Developing green inexpensive and effective adsorbents is critically needed for the elimination of sulfonamides from wastewater. The non-modified biochar exhibited limited adsorption capacity for sulfonamides. In this study, the attapulgite-doped biochar adsorbent (ATP/BC) was produced from attapulgite and rice straw by calcination. Compared with non-modified biochar, the specific surface area of ATP/BC increased by 73.53–131.26%, and the average pore width of ATP/BC decreased 1.77–3.60 nm. The removal rates of sulfadiazine and sulfamethazine by ATP/BC were 98.63% and 98.24%, respectively, at the mass ratio of ATP to rice straw = 1:10, time = 4 h, dosage = 2 g∙L−1, pH = 5, initial concentration = 1 mg∙L−1, and temperature = 20 °C. A pseudo-second-order kinetic model (R2 = 0.99) and the Freundlich isothermal model (R2 = 0.99) well described the process of sulfonamide adsorption on ATP/BC. Thermodynamic calculations showed that the adsorption behavior of sulfonamides on the ATP/BC was an endothermic (ΔH > 0), random (ΔS > 0), spontaneous reaction (ΔG −1 > ΔG). The potential adsorption mechanisms include electrostatic interaction, hydrogen bonding, π–π interaction, and Lewis acid–base interactions. This study provides an optional material to treat sulfonamides in wastewater and groundwater

    Purification of Micro-Polluted Lake Water by Biofortification of Vertical Subsurface Flow Constructed Wetlands in Low-Temperature Season

    No full text
    In this study, a novel lab-scale biofortification-combination system (BCS) of Oenanthe javanica and Bacillus series was developed to improve the treatment ability of vertical subsurface flow constructed wetlands (VSFCW) at low temperatures (0–10 °C). The results showed that BCS-VSFCW overcame the adverse effects of low temperature and achieved the deep removal of nutrients. In addition, the removal rates of chemical oxygen demand (COD), ammonia nitrogen (NH4+-N), total nitrogen (TN), and total phosphorus (TP) by BCS-VSFCW were 38.65%, 28.20%, 18.82%, and 14.57% higher than those of blank control, respectively. During the experiment, Oenanthe javanica and low temperature tolerant Bacillus complemented each other in terms of microbial activity and plant uptake. Therefore, VSFCW combined with Oenanthe javanica and low temperature tolerant Bacillus has a promising future in low temperature (<10 °C) areas of northern China

    Effects of Si-Miao-Yong-An decoction on myocardial I/R rats by regulating gut microbiota to inhibit LPS-induced TLR4/NF-κB signaling pathway

    No full text
    Abstract Background Coronary Artery Disease (CAD) is primarily caused by inflammation which is closely linked to the gut microbiota. Si-Miao-Yong-An (SMYA) decoction is a traditional Chinese herbal formula with anti-inflammatory properties that found to be effective against CAD. However, it is still unclear whether SMYA can modulate gut microbiota and whether it contributes to the improvement of CAD by reducing inflammation and regulating the gut microbiota. Methods The identification of components in the SMYA extract was conducted using the HPLC method. A total of four groups of SD rats were orally administered with SMYA for 28 days. The levels of inflammatory biomarkers and myocardial damage biomarkers were measured through ELISA, while echocardiography was used to assess heart function. Histological alterations in the myocardial and colonic tissues were examined following H&E staining. Western blotting was performed to evaluate protein expression, whereas alterations in gut microbiota were determined by 16 s rDNA sequencing. Results SMYA was found to enhance cardiac function and decrease the expression of serum CK-MB and LDH. SMYA was also observed to inhibit the TLR4/NF-κB signaling pathway by downregulating the protein expression of myocardial TLR4, MyD88, and p-P65, leading to a reduction in serum pro-inflammatory factors. SMYA modified the composition of gut microbiota by decreasing the Firmicutes/Bacteroidetes ratio, modulating Prevotellaceae_Ga6A1 and Prevotellaceae_NK3B3 linked to the LPS/TLR4/NF-κB pathway, and increasing beneficial microbiota such as Bacteroidetes, Alloprevotella, and other bacterial species. Moreover, SMYA was found to safeguard the intestinal mucosal and villi structures, elevate the expression of tight junction protein (ZO-1, occludin), and reduce intestinal permeability and inflammation. Conclusions The results indicate that SMYA has the potential to modulate the gut microbiota and protect the intestinal barrier, thereby reducing the translocation of LPS into circulation. SMYA was also found to inhibit the LPS-induced TLR4/NF-κB signaling pathway, leading to a decrease in the release of inflammatory factors, which ultimately mitigated myocardial injury. Hence, SMYA holds promise as a therapeutic agent for the management of CAD

    Simulation and Experimental Study on Jet Velocity of Zr-Based Amorphous Alloy Liner

    No full text
    Zr-based amorphous alloy is a new energetic material that has been closely monitored and extensively studied for the design of highly effective shaped charge warheads in recent years. In order to accurately determine the motion parameters of shaped charge jets during the detonation-driven formation process of Zr-based amorphous alloy liners, we prepared conical ZrCuNiAlAg liners by vacuum die casting and supercooled liquid high-rheological-rate formation processes. Based on jet-formation numerical simulation, pulsed X-ray imaging and copper foil target velocity measuring tests were conducted to identify the variation trend of the jet velocity of Zr-based amorphous alloy liners with time. The jet velocities at typical moments in the free flight stage were verified. The research results showed that Zr-based amorphous alloy liners could produce solid jets, whose velocity was in gradient descent from the head to the tail, and that the jet’s head velocity peaked at 12 μs and then slowly decreased with time. The average velocities measured by the X-ray imaging and copper foil target tests were 6913 m/s and 7177 m/s, respectively, and both of them were in good agreement with the simulation results, verifying the accuracy of the numerical simulation model for jet formation. The formation processes of shaped charge liners were found to affect the mechanical properties of the material and thus, the jet’s formation process and motion parameters. The Zr-based amorphous alloy liner formed by the supercooled liquid-phase high-rheological-rate formation process exhibited a jet velocity 6.5% higher than that formed by the vacuum die casting process

    Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality

    No full text
    Background: The efficacy of montelukast (MONT), a cysteinyl leukotriene receptor antagonist, in nonasthmatic eosinophilic bronchitis (NAEB), especially its influence on cough associated life quality is still indefinite. We evaluated the efficacy of MONT combined with budesonide (BUD) as compared to BUD monotherapy in improving life quality, suppressing airway eosinophilia and cough remission in NAEB. Methods: A prospective, open-labeled, multicenter, randomized controlled trial was conducted. Patients with NAEB (aged 18-75 years) were randomized to inhaled BUD (200 μg, bid) or BUD plus oral MONT (10 μg, qn) for 4 weeks. Leicester cough questionnaire (LCQ) life quality scores, cough visual analog scale (CVAS) scores, eosinophil differential ratio (Eos), and eosinophil cationic protein (ECP) in induced sputum were monitored and compared. Results: The control and MONT groups contained 33 and 32 patients, respectively, with similar baseline characteristics. Significant with-in group improvement in CVAS, LCQ scores, Eos, and ECP was observed in both groups during treatment. After 2-week treatment, add-on treatment of MONT was significantly more effective than BUD monotherapy for CVAS decrease and LCQ scores improvement (both P < 0.05). Similar results were seen at 4-week assessment (both P < 0.05). 4-week add-on therapy of MONT also resulted in a higher percentage of patients with normal sputum Eos (<2.5%) and greater decrease of ECP (both P < 0.05). Conclusions: MONT combined with BUD was demonstrated cooperative effects in improvement of life quality, suppression of eosinophilic inflammation, and cough remission in patients with NAEB

    Comprehensive Identification of Guan-Xin-Shu-Tong Capsule via a Mass Defect and Fragment Filtering Approach by High Resolution Mass Spectrometry: In Vitro and In Vivo Study

    No full text
    The Guan-Xin-Shu-Tong capsule (GXSTC) is a well-known traditional Chinese medicine that is used for the treatment of coronary heart disease. Despite its common use in China, basic pharmacological research on its active components is limited. A comprehensive analytical method using quadrupole-time-of-flight mass spectrometry (Q-TOF/MS), specifically with the Triple TOF 5600 platform, was developed to characterize the compounds in the GXSTC powder itself (in vitro) as well as the active components in healthy and heart disease model rats after its oral administration (in vivo). The 5600 platform was operated in both positive and negative ion modes, before the raw data were processed using the extracted ion chromatography (EIC), mass defect filtering (MDF) and fragment filtering (FF) techniques. With the aid of reference compounds for retention time and fragment ion comparisons, 18 compounds were unambiguously identified in vitro. An additional 56 other compounds were tentatively characterized using the accurate quasi-molecular ion mass and Tandem mass spectrometry (MS/MS) fragmentation pattern strategies. Among them, 30 compounds were characterized based on the MDF and FF approaches. Normal rats in addition to hyperlipidemic (HL) and acute blood stasis (ABS) model rats were given a single oral dose of GXSTC solution for subsequent blood analysis at 1 and 2 h after administration. A total of 24 prototypecomponents and 20 metabolites derived from GXSTC were differentially detected across the three animal groups, including the absence of four phase II phenolic acid metabolites in the ABS group and the presence of three diterpenoid-related metabolites exclusive to the HL group. The use of reference compounds as well as the mass defect and fragment-filtering strategies were critical to identify GXSTC compounds in vitro and in vivo. This can be used for further quality control and pharmacological studies aimed at characterizing the active and potential beneficial compounds of this ancient medicine
    • …
    corecore